Moreover, we discuss the potential therapeutic effect of angiotensin receptor blockers (ARBs), ACE inhibitors (ACE-I), and related substances such as vitamin D and bradykinin for preventing endothelial dysfunction. The gene discussed is KNG1; the disease is endothelial dysfunction.